
DuPont is rated Buy, offering secular growth and margin expansion at an attractive valuation, with strong exposure to healthcare, water, EV, and aerospace markets. Healthcare and Water Technologies dr
DuPont remains undervalued, but I move from Strong Buy to Buy due to Q3 guidance concerns and currency headwinds. Q2 is expected to deliver a small beat, driven by strong healthcare and aerospace, tho